Mirum Pharmaceuticals (MIRM) Stock Price

$66.68 1.8%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    7

  • Technical

    8

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Mirum Pharmaceuticals, AI stock picks, stock alerts and much more.

Sign up

MIRM AI Stock Analysis

AI stock analysis for MIRM is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Mirum Pharmaceuticals (MIRM) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Mirum Pharmaceuticals (MIRM) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Mirum Pharmaceuticals (MIRM), currently trading at $66.68, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About MIRM

LSE

  • Mirum Pharmaceuticals, Inc.

  • Symbol

    MIRM

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    3.3B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $20.23
0.00%
7
INO Inovio Pharmaceuticals
INO		 $1.9
2.2%
3
MRNA Moderna
MRNA		 $28.09
0.3%
3
AVXL Anavex Life Sciences
AVXL		 $9.59
3.6%
5
BBIO BridgeBio Pharma
BBIO		 $49.02
4.5%
6

News

Mirum Pharmaceuticals: Q2 Results Continue To Show Positive Momentum

Mirum Pharmaceuticals: Q2 Results Continue To Show Positive Momentum
August 11, 2025. seekingalpha.com
MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View

MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
August 7, 2025. zacks.com
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2025 Earnings Call Transcript

Mirum Pharmaceuticals, Inc. (MIRM) Q2 2025 Earnings Call Transcript
August 6, 2025. seekingalpha.com
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates
August 6, 2025. zacks.com

MIRM Alternative Data

Web Traffic

Mirum Pharmaceuticals receives an estimated 10988 monthly visitors to mirumpharma.com.

  • Web Traffic

    10988

  • Change from Previous Month

    52.5%

  • 3 Month Change

    11.8%

  • YoY Change

    11.8%

Facebook Engagement

Mirum Pharmaceuticals has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    100%

  • YoY Change

    100%

Instagram Followers

Mirum Pharmaceuticals has 445 Instagram Followers on its main Instagram account, up by 0.7% over the last month.

  • Instagram Followers

    445

  • Daily Change

    0.2%

  • 1 Month Change

    0.7%

  • 3 Month Change

    5.2%

  • YoY Change

    5.2%

Youtube Subscribers

Mirum Pharmaceuticals has 180 subscribers on its main Youtube channel, up by 0.6% over the last month.

  • Youtube Subscribers

    180

  • Daily Change

    0%

  • 1 Month Change

    0.6%

  • 3 Month Change

    1.1%

  • YoY Change

    1.1%

LinkedIn Followers

39,192 are following Mirum Pharmaceuticals on LinkedIn, up by 1.2% over the last month.

  • LinkedIn Followers

    39192

  • Daily Change

    0%

  • 1 Month Change

    1.2%

  • 3 Month Change

    3.1%

Job Postings

Mirum Pharmaceuticals currenly has an estimated 19 open job postings, up by 11.8% over the last month.

  • Job Postings

    19

  • Daily Change

    0%

  • 1 Month Change

    11.8%

  • 3 Month Change

    26.7%

  • YoY Change

    26.7%

LinkedIn Employees

According to LinkedIn, Mirum Pharmaceuticals has 385 employees, up by 1.3% over the last month.

  • LinkedIn Employees

    385

  • Daily Change

    0.3%

  • 1 Month Change

    1.3%

  • 3 Month Change

    5.8%

  • YoY Change

    5.8%

Reddit Mentions

Mirum Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

Mirum Pharmaceuticals has 620 Twitter Followers on its main Twitter (also known as X) account, which is up by 1% over the last month.

  • Twitter Followers

    620

  • Daily Change

    0%

  • 1 Month Change

    1%

  • 3 Month Change

    2.6%

  • YoY Change

    2.6%

Business Outlook

According to employee reviews, the business outlook among employees at Mirum Pharmaceuticals is 63 out of 100 (bullish).

  • Business Outlook

    63

  • Change from Previous Month

    0%

  • 3 Month Change

    18.9%

  • YoY Change

    18.9%

News Mentions

Mirum Pharmaceuticals was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

MIRM Financials

MIRM Key Metrics

  • Total Revenue

    $99.4M

  • Net Income

    -$23.8M

  • Earnings per Share

    -$0.49

  • Free cash flow

    -$5.1M

  • EBITDA

    -$14.7M

  • EBITDA Ratio

    -0.148178

  • Total Assets

    $670.8M

MIRM 2-year Revenue & Income
MIRM 2-year Free Cash Flow

MIRM Technicals

MIRM SMA
MIRM RSI

FAQ

What's the current price of Mirum Pharmaceuticals (MIRM) Stock?
The price of an Mirum Pharmaceuticals (MIRM) share is $66.68.

What's the market cap of Mirum Pharmaceuticals?
The current market cap of Mirum Pharmaceuticals is 3.3B.

Should I buy or sell MIRM?
Multiple alternative data signals suggest that Mirum Pharmaceuticals stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Mirum Pharmaceuticals a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Mirum Pharmaceuticals stock. The bullish indicators suggest that Mirum Pharmaceuticals' growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Mirum Pharmaceuticals (MIRM) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Mirum Pharmaceuticals stock, given the bullish outlook.

What are some stocks similar to Mirum Pharmaceuticals (MIRM) that investors often compare it to?
Mirum Pharmaceuticals (MIRM) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Mirum Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Mirum Pharmaceuticals' stock price to be around $71.17 in 2026. Starting from the current price of $66.68, this represents a 6.7% change in price, indicating a bullish outlook for the stock.

How to buy Mirum Pharmaceuticals (MIRM) Stock?
Mirum Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Mirum Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.